Korean Journal of Head & Neck Oncology (대한두경부종양학회지)

The Korean Society for Head and Neck Oncology (대한두경부종양학회)
권호 표지

Synchronous Mucoepidermoid Carcinoma of Parotid Gland and Unicentric Cervical Cathleman's Disease : A Case Report

점액표피양 암종과 동반된 경부 캐슬만 병 1예

  • Noh, Min Ho (Department of Otolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine) ;
  • Bae, Kong Geun (Department of Otolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine) ;
  • Ban, Myung Jin (Department of Otolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine) ;
  • Park, Jae Hong (Department of Otolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine) ;
  • Lee, Seung Won (Department of Otolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine) ;
  • Park, Ki Nam (Department of Otolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine) ;
  • Kim, Jae Wook (Department of Otolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine) ;
  • Koh, Yoon Woo (Department of Otorhinolaryngology, Yonsei University College of Medicine)
  • 노민호 (순천향대학교 의과대학 천안병원 이비인후과학교실) ;
  • 배공근 (순천향대학교 의과대학 천안병원 이비인후과학교실) ;
  • 반명진 (순천향대학교 의과대학 천안병원 이비인후과학교실) ;
  • 박재홍 (순천향대학교 의과대학 천안병원 이비인후과학교실) ;
  • 이승원 (순천향대학교 의과대학 천안병원 이비인후과학교실) ;
  • 박기남 (순천향대학교 의과대학 천안병원 이비인후과학교실) ;
  • 김재욱 (순천향대학교 의과대학 천안병원 이비인후과학교실) ;
  • 고윤우 (연세대학교 의과대학 이비인후과학교실)
  • Received : 2015.03.19
  • Accepted : 2015.05.09
  • Published : 2015.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Castleman's disease is an uncommon lymphoproliferative disorder. The disorder can be classified based on histological subtype, such as hyaline vascular type, plasma cell type, and mixed type, and can also be clinically divided into either unicentric or multicentric type. Its exact pathophysiology is not clearly identified. The unicentric type is able to be treated by surgical resection. However, there is no standard treatment modlity for the multicentric type. Treatment of multicentric type includes anti-cancer chemotherapy and radiation therapy. Recently, authors have experienced a rare case of unicentric type of Castleman's disease accompanying a mucoepidermoid carcinoma of parotid gland and report a case which is discussed with references.

Keywords

References

  1. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasmacell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29(3):670-683. https://doi.org/10.1002/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#
  2. Dispenzieri A, Gertz MA. Treatment of Castleman's disease. Curr Treat Options Oncol. 2005;6(3):255-266. https://doi.org/10.1007/s11864-005-0008-z
  3. Case records of the Massachusetts General Hospital Weekly Clinicopathological Exercises: Case 40011. N Engl J Med. 1954;250(1):26-30. https://doi.org/10.1056/NEJM195401072500107
  4. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9(4):822-830. https://doi.org/10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4
  5. Kumar BN, Jones TJ, Skinner DW. Castle-man's disease: an unusal cause of a neck mass. Oto Rhino Laryngol. 1997;59:339-340.
  6. Mahesh Deshmukh, Munita Bal, Prashant Deshpande, NA Jambhekar. Synchronous Squamous Cell Carcinoma of Tongue and Unicentric Cervical Castleman's Disease Clinically Mimicking a Stage IV Disease: A Rare Association or Coincidence?. Head and Neck Pathol. 2011;5:180-183. https://doi.org/10.1007/s12105-011-0240-8
  7. McCarty MJ, Vukelja SJ, Banks PM, Weiss RB. Angiofollicular lymph node hyperplasia(Castleman's disease). Cancer Treat Rev. 1995;21(4):291-310. https://doi.org/10.1016/0305-7372(95)90034-9
  8. Soumerai JD, Sohani AR, Abramson JS. Diagnosis and management of castleman disease. Cancer control. 2014;24(4):266-278.
  9. Hoffmann C, Schmid H, Muller M, Teutsch C, van Lunzen J, Esser S, Wolf T, et al. Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease. Blood. 2011;118(13):3499-3503.
  10. Kurzrock R, Voorhees PM, Casper C, Furman RR, Fayad L, Lonial S, Borghaei H, et al. A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-hodgkin lymphoma, multiple myeloma, or Castleman disease. Clin Cancer Res. 2013;19(13):3659-3670. https://doi.org/10.1158/1078-0432.CCR-12-3349
  11. Senanayake S, Kelly J, Lloyd A, Waliuzzaman Z, Goldstein D, Rawlinson W. Multicentric Castleman's disease treated with antivirals and immunosuppressants. J Med Virol. 2003;71(3):399-403. https://doi.org/10.1002/jmv.10500